Los vectores de Pichia pPICZ A, B y C están diseñados para una clonación y selección sencillas, así como paraMás información
Have Questions?
Número de catálogo
Cantidad
V19020
20μg
Número de catálogo V19020
Precio (EUR)
1.916,00
20 µg
Añadir al carro de la compra
Cantidad:
20μg
Precio (EUR)
1.916,00
20 µg
Añadir al carro de la compra
Los vectores de Pichia pPICZ A, B y C están diseñados para una clonación y selección sencillas, así como para una expresión de alto nivel y una detección y purificación rápidas de la proteína recombinante. Estos vectores contienen el gen de resistencia a Zeocin™ para la selección directa de cepas integrantes multicopia. Al seleccionar con cantidades cada vez mayores de Zeocin™, se obtienen cepas con múltiples copias del gen de interés integrado en el genoma. El aumento del número de copias del gen de interés en la cepa de Pichia recombinante puede derivar en niveles de expresión más altos. Los vectores se incluyen en el kit de expresión de Pichia EasySelect™ (n.º de cat. K1740-01).
Entre las características de los vectores pPICZ se incluyen:
• Promotor de AOX1 inducible para la expresión de alto nivel en la etiqueta de epítopo de Pichia pastoris c-myc para una detección cómoda con un anticuerpo anti-myc • Etiqueta polihistidina (6xHis) de terminal C para una rápida purificación con resina quelante de níquel y detección con el anticuerpo anti-His (terminal de C) • Resistencia a Zeocin™ para la selección directa de integrantes multicopia
Para uso exclusivo en investigación. No apto para uso en procedimientos diagnósticos.
Especificaciones
Resistencia bacteriana a los antibióticosZeocin™ (Zeor)
Tipo de productoVector de expresión de Pichia
Cantidad20μg
VectorpPIC
Método de clonaciónEnzimas de restricción/MCS
PromotorAOX1
Etiqueta de proteínaEtiqueta His (6x), Etiqueta de epítopo c-Myc
Unit Size20 µg
Contenido y almacenamiento
20 μg cada uno de pPICZ A, B, & C suspendido en 10 mM Tris-HCl, 1 mM EDTA, pH 8.0. También se incluye una cepa de control positivo GS115/pPICZ/lacZ.
Conservar los vectores de -5 a -30°C.
Preguntas frecuentes
When selecting for blasticidin-resistant transformants in the X-33 strain using pPIC6/pPIC6α vectors, why do I get large and small colonies on YPD plates containing 300 µg/ml blasticidin?
Generally, large colonies represent transformants containing pPIC6/pPIC6α integrants, while small colonies represent transformants containing pPIC6/pPIC6α non-integrants. These non-integrants have transduced the pPIC6/pPIC6α plasmid, and therefore, exhibit a low level of blasticidin resistance in the initial selection process. Upon subsequent screening, these non-integrant transformants do not retain blasticidin resistance.
When choosing a blasticidin-resistant transformant for your expression studies, we recommend that you pick blasticidin-resistant colonies from the initial transformation plate and streak them on a second YPD plate containing the appropriate concentration of blasticidin. Select transformants that remain blasticidin-resistant for further studies.
My transformation is not working. Do you have any suggestions?
Here are some suggestinos:
- Make sure that you have harvested cells during log-phase growth (OD <1.0 generally).
- If electroporation is being used, see the electroporator manual for suggested conditions. Vary electroporation parameters if necessary.
- Use more DNA.
- Use freshly made competent cells.
- If the LiCl transformation method is being used, try boiling the carrier DNA.
My spheroplasting of Pichia worked twice, but hasn't worked since. The OD of the culture simply does not drop.
Here are some things to consider:
- If the OD of cells that are used is too high, they will not spheroplast. Do not overgrow cells.
- Do not use old cells and make sure that they are in log phase of growth.
- Make sure to mix zymolyase well before using. Zymolyase is more of a suspension than a solution.
- Make the PEG solution fresh each time and check the pH.
Is there a recommended protocol for fermentation using constitutive expression vectors such as pGAPZ?
Use the following high cell density protocol for pGAP clones. Feed carbon until the desired density is reached (300 to 400 g/L wet cell weight (WCW)). If the protein is well-behaved in the fermenter, increase to 300-400 g/L WCW as with methanol inducible clones. These densities can be reached in less than 48 hours of fermentation. We have fermented constitutive expressers on glycerol using these protocols with good results. Some modifications to the Fermentation Basal Salts Medium that you might want to make are:
1) Substitute 2% dextrose for the 4% glycerol in the batch medium.
2) Substitute 40% dextrose for the 50% glycerol in the fed-batch medium.
3) Feed the 40% dextrose at 12 mL/L/hr (Jim Cregg has published data on expression using several carbon sources as substrates; dextrose gave the highest levels of expression).
4) Yeast extract and peptone may be added to the medium for protein stability.
One warning: If you are working with His- strains, they remain His- after transformation with pGAPZ. Fermentation in minimal medium will require addition of histidine to the fermenter.
In vivo functional assay of a recombinant aquaporin in Pichia pastoris.
Authors:Daniels MJ, Wood MR, Yeager M,
Journal:Appl Environ Microbiol
PubMed ID:16461705
The water channel protein PvTIP3;1 (alpha-TIP) is a member of the major intrinsic protein (MIP) membrane channel family. We overexpressed this eukaryotic aquaporin in the methylotrophic yeast Pichia pastoris, and immunogold labeling of cellular cryosections showed that the protein accumulated in the plasma membrane, as well as vacuolar and other ... More
The crystal structure of human CD21: Implications for Epstein-Barr virus and C3d binding.
Authors: Prota Andrea E; Sage David R; Stehle Thilo; Fingeroth Joyce D;
Journal:Proc Natl Acad Sci U S A
PubMed ID:12122212
Human complement receptor type 2 (CD21) is the cellular receptor for Epstein-Barr virus (EBV), a human tumor virus. The N-terminal two short consensus repeats (SCR1-SCR2) of the receptor interact with the EBV glycoprotein gp350/220 and also with the natural CD21 ligand C3d. Here we present the crystal structure of the ... More
The donor substrate specificity of the human beta 1,3-glucuronosyltransferase I toward UDP-glucuronic acid is determined by two crucial histidine and arginine residues.
The human beta1,3-glucuronosyltransferase I (GlcAT-I) plays a key role in proteoglycan biosynthesis by catalyzing the transfer of glucuronic acid onto the trisaccharide-protein linkage structure Galbeta1,3Galbeta1,4Xylbeta-O-Ser, a prerequisite step for polymerization of glycosaminoglycan chains. In this study, we identified His(308) and Arg(277) residues as essential determinants for the donor substrate (UDP-glucuronic ... More